There are 412 resources available
1419P - TACSTD2 (Trop-2) constitutes a promising antibody-drug conjugate target for patients with non-small cell lung cancer brain metastases
Presenter: Sara Hijazo-Pechero
Session: Poster session 20
1049P - Phase Ib/II trial of envafolimab, a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, plus lenvatinib in patients with selected advanced solid tumors
Presenter: Tianshu Liu
Session: Poster session 19
1323MO - Immune evasion across space and time in patients with lung cancer enrolled in the PEACE autopsy study
Presenter: Sonya Hessey
Session: Mini oral session 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
658MO - Phase I study of SHR-A2009, a HER3-targeted ADC, in advanced solid tumors
Presenter: Yi-Long Wu
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1507TiP - Phase Ib multicenter study of trastuzumab deruxtecan (T-DXd) and immunotherapy with or without chemotherapy in first-line treatment of patients (pts) with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) and HER2 overexpression (OE): DESTINY-Lung03
Presenter: David Planchard
Session: Poster session 21
1383P - Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study
Presenter: Anna Kron
Session: Poster session 20
1077TiP - TAK-500 as a single agent and in combination with pembrolizumab in patients (pts) with advanced solid tumors: Rationale and design of a phase I/II study
Presenter: Harshabad Singh
Session: Poster session 19
1357P - Bevacizumab improved prognosis for advanced EGFR mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy
Presenter: YuanLiang Zhou
Session: Poster session 19
1293MO - Safety and efficacy of hypo- and conventionally fractionated thoracic radiotherapy plus durvalumab in elderly or frail NSCLC stage III patients unfit for chemotherapy: Interim results from the TRADE-hypo trial
Presenter: Farastuk Bozorgmehr
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
185P - Real-world data analysis of genomic profiling-matched targeted therapy outcomes in patients with fusion-positive NSCLC
Presenter: Jyoti Patel
Session: Poster session 01